High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
about
Optimum duration of regimens for Helicobacter pylori eradicationTreatment of Helicobacter pylori infection: Current and future insightsMeta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?Primary Antibiotic Resistance of Helicobacter pylori in China.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Treatment of Helicobacter pylori infection 2011.Helicobacter pylori in First Nations and recent immigrant populations in Canada.Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients.Helicobacter pylori infection in India from a western perspective.Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trialReview article: the global emergence of Helicobacter pylori antibiotic resistance.Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from ChinaCurrent progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea.Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.Guidelines for treatment of Helicobacter pylori in the East and West.Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection.Attempts to enhance the eradication rate of Helicobacter pylori infectionReview: clinical management of Helicobacter pylori infection in China.Role of bismuth in improving Helicobacter pylori eradication with triple therapy.Eradication of Helicobacter pylori Infection.Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies.Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.H. pylori Management in ASEAN: the Bangkok Consensus Report.Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype.Rabeprazole, Minocycline, Amoxicillin, and Bismuth as First-Line and Second-Line Regimens for Helicobacter pylori Eradication.Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.Adding diclofenac to Helicobacter pylori eradication regimen.Rescue Therapy for Helicobacter pylori Infection 2012.A new paradigm for clinical trials in antibiotherapy?Comparison of Helicobacter pylori Eradication Rates of 2-week Levofloxacin Containing Triple Therapy, Levofloxacin Containing Bismuth Quadruple Therapy and Standard Bismuth Quadruple Therapy as a First-line Regimen.
P2860
Q24201841-5374A928-AD10-4B3B-9819-8DEA46A997F4Q26769707-8EDE32AB-0EC9-4ACD-AE4A-1907A868E8E3Q28082104-1F9F9720-9FF1-4D20-B2A8-C4F51FBD1BBDQ30235219-7E88A5FE-5221-4FC9-8765-89AA5FF7139CQ33639114-0A97A834-12B0-448E-ACBD-CCFCE394D2E1Q34028419-5C387968-C166-4CC6-9A4A-966492C86B4FQ35744635-340A347B-9D5E-4633-B940-CC3468DADEFDQ36215547-764529C9-02A5-4E42-B6C2-B6590641D08AQ36447013-B2F1C8C1-72B8-4DFA-9310-5BB710C523FBQ36449962-2D663CDA-32A1-4496-98F9-6AFA07BDF049Q36614237-DC5AF265-7704-4BB9-9E61-3202460645AFQ37340339-106D18BA-1F41-441F-A8FE-96593E450BA0Q37397744-3C7C4278-4644-457D-8C58-8BCD9C1CB567Q37587260-81AA9608-2F1F-4155-BCB5-DD5F445357A1Q37656247-951AC2C0-1511-42D0-B3F9-62123ECB24FFQ37912220-FAB3F2BC-B17F-4F62-AB2C-3A1B0B97B084Q38072783-0DDA8A65-F63A-4A1A-9780-61FB8093203BQ38212213-3680C2B3-E819-4665-8FEB-832B3B0FA6ACQ38266432-2AD31FCE-298E-4450-9EBF-5C36E02C8636Q38723877-A685C27E-C88B-4625-8241-2E8B7D3AE616Q38833959-AD4CF5C3-E5A4-43DE-A3F5-1AE282CE8EDAQ39278632-BD444184-E2E7-4411-9902-62EC19879C56Q39588933-07DF712F-F674-486F-B006-0504F3CC0EE3Q40100019-2E9CDCFF-1A66-4E47-BACA-366455C4EFC9Q40268942-F2F00D13-F2DE-4EFD-8413-B700F4FB06BBQ40722225-62395325-BCD8-48B6-84BA-60B2F6C5E167Q41016205-49CD874D-32F5-46F3-8987-E5EB58A5DC3AQ41024354-6B525C0D-F021-458E-849E-3F4693DEA396Q42129420-F669F75D-E759-4F19-98F5-CC29DF81C1F5Q42838869-5B1BD882-2D51-4EBD-81C8-6A4392555F43Q50050397-D1321376-D7A7-4B60-B5FA-E3D171409E64
P2860
High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
High efficacy of 14-day triple ...... licobacter pylori eradication.
@en
High efficacy of 14-day triple ...... licobacter pylori eradication.
@nl
type
label
High efficacy of 14-day triple ...... licobacter pylori eradication.
@en
High efficacy of 14-day triple ...... licobacter pylori eradication.
@nl
prefLabel
High efficacy of 14-day triple ...... licobacter pylori eradication.
@en
High efficacy of 14-day triple ...... licobacter pylori eradication.
@nl
P2093
P2860
P1433
P1476
High efficacy of 14-day triple ...... licobacter pylori eradication.
@en
P2093
Qing Zheng
Qinjuan Sun
Shudong Xiao
Wenzhong Liu
Xiao Liang
P2860
P304
P356
10.1111/J.1523-5378.2010.00758.X
P577
2010-06-01T00:00:00Z